Acute myocardial infarction(AMI)is associated with a challenging prognosis.Notably,the Tongxinluo capsule(TXL),a proprietary Chinese medicine,has garnered attention for its potential therapeutic effects.This study aim...Acute myocardial infarction(AMI)is associated with a challenging prognosis.Notably,the Tongxinluo capsule(TXL),a proprietary Chinese medicine,has garnered attention for its potential therapeutic effects.This study aimed to elucidate the concealed pharmacological benefits of TXL in AMI patients and identify pertinent immunological targets.In the GSE66360 dataset,172 upregulated genes and 16 downregulated genes were discerned.Subsequently,803 key targets of TXL were meticulously sifted through the Traditional Chinese Medicine Systems Pharmacology(TCMSP)and Herbal Ingredients’Targets(HERB)databases.The intersection of these datasets was determined using Venn diagrams.Gene Ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)enrichment analyses unveiled that these genes were predominantly associated with the NF-kappa B signaling pathway,TNF signaling pathway,IL-17 signaling pathway,and other signaling cascades.The extent of immune infiltration between AMI and control samples was assessed using Cibersort,and Spearman’s rank correlation was employed to explore the relationship between immune cells and the amalgamated genes.This investigation revealed that the amelioration of AMI with TXL might be linked to an augmentation in mast cell-activated cells and neutrophil invasion.The Weighted Gene Co-expression Network Analysis(WGCNA)identified gene modules strongly correlated with 22 immune cells.These modules were further scrutinized using the Cibersort algorithm,leading to the recognition of eight genes deemed pivotal as potential novel molecular markers for TXL treatment of AMI.The infiltration of defense cells was also found to exert a significant impact.This study contributed to our understanding of the pharmacological mechanisms of TXL and provided valuable insights for future investigations into potential targets for AMI immunotherapy.展开更多
文摘Acute myocardial infarction(AMI)is associated with a challenging prognosis.Notably,the Tongxinluo capsule(TXL),a proprietary Chinese medicine,has garnered attention for its potential therapeutic effects.This study aimed to elucidate the concealed pharmacological benefits of TXL in AMI patients and identify pertinent immunological targets.In the GSE66360 dataset,172 upregulated genes and 16 downregulated genes were discerned.Subsequently,803 key targets of TXL were meticulously sifted through the Traditional Chinese Medicine Systems Pharmacology(TCMSP)and Herbal Ingredients’Targets(HERB)databases.The intersection of these datasets was determined using Venn diagrams.Gene Ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)enrichment analyses unveiled that these genes were predominantly associated with the NF-kappa B signaling pathway,TNF signaling pathway,IL-17 signaling pathway,and other signaling cascades.The extent of immune infiltration between AMI and control samples was assessed using Cibersort,and Spearman’s rank correlation was employed to explore the relationship between immune cells and the amalgamated genes.This investigation revealed that the amelioration of AMI with TXL might be linked to an augmentation in mast cell-activated cells and neutrophil invasion.The Weighted Gene Co-expression Network Analysis(WGCNA)identified gene modules strongly correlated with 22 immune cells.These modules were further scrutinized using the Cibersort algorithm,leading to the recognition of eight genes deemed pivotal as potential novel molecular markers for TXL treatment of AMI.The infiltration of defense cells was also found to exert a significant impact.This study contributed to our understanding of the pharmacological mechanisms of TXL and provided valuable insights for future investigations into potential targets for AMI immunotherapy.
